Abstract
This report analyzes the worldwide markets for Biogenerics in US$ Million. The
report provides separate comprehensive analytics for the US, Europe, and Rest
of World. Annual forecasts are provided for each region for the period of 2007
through 2013. The report profiles 42 companies including many key and niche
players worldwide such as Biocon Limited, BioPartners, BioGeneriX AG, Cangene
Corporation, Cipla Ltd., Dr. Reddy' s Laboratories, GeneMedix, LG Life
Sciences, Pliva d.d., Ranbaxy Laboratories Limited, Sandoz International GmbH,
Stada Arzneimittel, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals
USA, and Wockhardt Limited. Market data and analytics are derived from primary
and secondary research. Company profiles are mostly extracted from URL
research and reported select online sources.
View Cart
